The Role of Genetics in the Surgical Management of Inflammatory Bowel Disease

Tara M. Connelly, Walter Koltun

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The relatively recent discoveries of >100 genes potentially involved with the etiology of inflammatory bowel disease (IBD) have stimulated intense research. The study of the pathophysiologic consequences of defects in these genes and the potential for a more careful classification of IBD patients based on genotype are two evolving benefits of this newfound knowledge. However, the use of such genetic information in the clinical care of IBD patients, especially in the surgical field, has lagged. There are many unresolved surgical issues in IBD management that hold hope for improvement through the use of genetic information in the individual patient. This includes, for example, identifying Crohn's disease patients at increased risk for recurrence after surgery to institute earlier prophylactic measures or maximize the use of bowel length preserving procedures. In the case of ulcerative colitis, genetics may help in preoperative patient selection by predicting which patients might suffer from severe pouchitis or pouch-threatening complications, such as fistuli or strictures. Similarly, the imperfect ability of colonoscopy to identify colitic patients who develop cancer may be solved by genetic markers that would predict malignant degeneration and so allow more effective prophylactic surgery.

Original languageEnglish (US)
Pages (from-to)44-50
Number of pages7
JournalSeminars in Colon and Rectal Surgery
Volume23
Issue number2
DOIs
StatePublished - Jun 1 2012

Fingerprint

Inflammatory Bowel Diseases
Pouchitis
Colonoscopy
Disease Management
Genetic Markers
Ulcerative Colitis
Crohn Disease
Patient Selection
Genes
Pathologic Constriction
Genotype
Recurrence
Research
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Gastroenterology

Cite this

@article{c3ef2281b0bc427591917bd6e50a979c,
title = "The Role of Genetics in the Surgical Management of Inflammatory Bowel Disease",
abstract = "The relatively recent discoveries of >100 genes potentially involved with the etiology of inflammatory bowel disease (IBD) have stimulated intense research. The study of the pathophysiologic consequences of defects in these genes and the potential for a more careful classification of IBD patients based on genotype are two evolving benefits of this newfound knowledge. However, the use of such genetic information in the clinical care of IBD patients, especially in the surgical field, has lagged. There are many unresolved surgical issues in IBD management that hold hope for improvement through the use of genetic information in the individual patient. This includes, for example, identifying Crohn's disease patients at increased risk for recurrence after surgery to institute earlier prophylactic measures or maximize the use of bowel length preserving procedures. In the case of ulcerative colitis, genetics may help in preoperative patient selection by predicting which patients might suffer from severe pouchitis or pouch-threatening complications, such as fistuli or strictures. Similarly, the imperfect ability of colonoscopy to identify colitic patients who develop cancer may be solved by genetic markers that would predict malignant degeneration and so allow more effective prophylactic surgery.",
author = "Connelly, {Tara M.} and Walter Koltun",
year = "2012",
month = "6",
day = "1",
doi = "10.1053/j.scrs.2012.02.002",
language = "English (US)",
volume = "23",
pages = "44--50",
journal = "Seminars in Colon and Rectal Surgery",
issn = "1043-1489",
publisher = "W.B. Saunders Ltd",
number = "2",

}

The Role of Genetics in the Surgical Management of Inflammatory Bowel Disease. / Connelly, Tara M.; Koltun, Walter.

In: Seminars in Colon and Rectal Surgery, Vol. 23, No. 2, 01.06.2012, p. 44-50.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Role of Genetics in the Surgical Management of Inflammatory Bowel Disease

AU - Connelly, Tara M.

AU - Koltun, Walter

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The relatively recent discoveries of >100 genes potentially involved with the etiology of inflammatory bowel disease (IBD) have stimulated intense research. The study of the pathophysiologic consequences of defects in these genes and the potential for a more careful classification of IBD patients based on genotype are two evolving benefits of this newfound knowledge. However, the use of such genetic information in the clinical care of IBD patients, especially in the surgical field, has lagged. There are many unresolved surgical issues in IBD management that hold hope for improvement through the use of genetic information in the individual patient. This includes, for example, identifying Crohn's disease patients at increased risk for recurrence after surgery to institute earlier prophylactic measures or maximize the use of bowel length preserving procedures. In the case of ulcerative colitis, genetics may help in preoperative patient selection by predicting which patients might suffer from severe pouchitis or pouch-threatening complications, such as fistuli or strictures. Similarly, the imperfect ability of colonoscopy to identify colitic patients who develop cancer may be solved by genetic markers that would predict malignant degeneration and so allow more effective prophylactic surgery.

AB - The relatively recent discoveries of >100 genes potentially involved with the etiology of inflammatory bowel disease (IBD) have stimulated intense research. The study of the pathophysiologic consequences of defects in these genes and the potential for a more careful classification of IBD patients based on genotype are two evolving benefits of this newfound knowledge. However, the use of such genetic information in the clinical care of IBD patients, especially in the surgical field, has lagged. There are many unresolved surgical issues in IBD management that hold hope for improvement through the use of genetic information in the individual patient. This includes, for example, identifying Crohn's disease patients at increased risk for recurrence after surgery to institute earlier prophylactic measures or maximize the use of bowel length preserving procedures. In the case of ulcerative colitis, genetics may help in preoperative patient selection by predicting which patients might suffer from severe pouchitis or pouch-threatening complications, such as fistuli or strictures. Similarly, the imperfect ability of colonoscopy to identify colitic patients who develop cancer may be solved by genetic markers that would predict malignant degeneration and so allow more effective prophylactic surgery.

UR - http://www.scopus.com/inward/record.url?scp=84860855900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860855900&partnerID=8YFLogxK

U2 - 10.1053/j.scrs.2012.02.002

DO - 10.1053/j.scrs.2012.02.002

M3 - Article

AN - SCOPUS:84860855900

VL - 23

SP - 44

EP - 50

JO - Seminars in Colon and Rectal Surgery

JF - Seminars in Colon and Rectal Surgery

SN - 1043-1489

IS - 2

ER -